Satellos

Manufacturing · Canada · 11-50 Employees

View Company Info for Free

Overview

Headquarters

200 Bay St Suite 2800, Toronto, Ontario,...

Phone Number

(647) 660-1780

Revenue

-

Stock Symbol

MSCLF

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Satellos

Satellos is dedicated to improving the treatment of Duchenne muscular dystrophy and other muscle diseases through the development of small molecule therapeutics. Their lead drug candidate, forazapadin, aims to enhance muscle regeneration by guiding muscle stem cells to divide asymmetrically, thereby repairing and regenerating damaged tissue. The company is also expanding its research to include other conditions characterized by muscle mass loss, such as facioscapulohumeral muscular dystrophy (FSHD). Satellos targets patients suffering from these debilitating muscle diseases, striving to restore their natural ability to regenerate muscle.Explore more
Satellos's Social MediaSIC Code 28,283NAICS Code 32,325Ticker OTC: MSCLFShow more

Satellos Org Chart

PhoneEmail
Wildon Farwell, Chief Medical Officer at Satellos
Canada flag for contact location.

Chief Medical Officer

PhoneEmail
Elizabeth Williams, Chief Financial Officer at Satellos
Canada flag for contact location.

Chief Financial Officer

PhoneEmail
DC
Canada flag for contact location.

Chief of Staff

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email

PhoneEmail
Get the full picture
Sign in to uncover key details.
AB
Canada flag for contact location.

Vice President, Clinical Operations

PhoneEmail
WA
Canada flag for contact location.

Vice President, Medical Affairs

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Satellos

Compare insights from companies similar to Satellos, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Satellos

11-50
Public
$41M
2018
Wildon Farwell, Chief Medical Officer at Satellos
Wildon FarwellChief Medical Officer
<$5M
11-50
Private
-
2007
DV
David VocadloChief Scientific Officer
<$5M
11-50
Private
$12.5M
2017
JM
Jim McGuireDirector of Pharmacology
<$5M
11-50
Private
<$5M
2008
MR
Mark ReedChief Scientific Officer
<$5M
11-50
Private
-
-
Amanda Mullen, Chief Operating Officer at AGADA Biosciences
Amanda MullenChief Operating Officer
Illustration of an envelope

Satellos Tech Stack

Top Manufacturing Companies

Frequently Asked Questions Regarding Satellos

What is Satellos's stock symbol?
Satellos's stock symbol is MSCLF
What is Satellos's official website?
Satellos's official website is www.satellos.com
What is Satellos's SIC code?
Satellos's SIC: 28,283
What is Satellos's NAICS code?
Satellos's NAICS: 32,325
How many employees does Satellos have?
Satellos has 11-50 employees
What industry does Satellos belong to?
Satellos is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Satellos competition?
Satellos top competitors include: Alectos Therapeutics, AGADA Biosciences, Treventis, Orion Biotechnology
What technology does Satellos use?
Some of the popular technologies that Satellos uses are: WordPress.org, PHP, Cloudflare Website Optimization, Barracuda Networks
Who is the CFO of Satellos?
Satellos's CFO is Elizabeth Williams
How do I contact Satellos?
Satellos contact info: Phone number: (647) 660-1780 Website: www.satellos.com
What does Satellos do?

Satellos is dedicated to improving the treatment of Duchenne muscular dystrophy and other muscle diseases through the development of small molecule therapeutics. Their lead drug candidate, forazapadin, aims to enhance muscle regeneration by guiding muscle stem cells to divide asymmetrically, thereby repairing and regenerating damaged tissue. The co... mpany is also expanding its research to include other conditions characterized by muscle mass loss, such as facioscapulohumeral muscular dystrophy (FSHD). Satellos targets patients suffering from these debilitating muscle diseases, striving to restore their natural ability to regenerate muscle.Read More

What are Satellos social media links?
Satellos Linkedin page Satellos Twitter page Satellos Facebook page
Who invested in Satellos?
Satellos has 5 investors including Haywood, Canaccord Genuity, LeedCo Financial Group and Parent Project Muscular Dystrophy.
Is Satellos a public company?
Yes, Satellos is a public company and is traded under the symbol MSCLF
See more information about Satellos

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.